Table 3.
Seroreactivity to HPV-16 and 52
| HPV DNA | NO = 60 | HPV-16 IgG | HPV-52 IgG | ||
|---|---|---|---|---|---|
| Positive (N = 16) N (%) | P Value | Positive (N = 7) N (%) | P Value | ||
| HPV-16 BTB | |||||
| Present | 18 | 12 (66.7) | < .00001 | 5 (27.8) | < .01 |
| Absent | 42 | 4 (9.5) | 2 (4.8) | ||
| HPV-16 BCC | |||||
| Present | 13 | 13 (100) | < .0000001 | 6 (46.2) | < .0001 |
| Absent | 47 | 3 (6.4) | 1 (2.1) | ||
| HPV-18 BTB | |||||
| Present | 6 | 3 (50) | NS | 1 (16.7) | NS |
| Absent | 54 | 13 (24.1) | 6 (11.1) | ||
| HPV-18 BCC | |||||
| Present | 3 | 2 (66.7) | NS | 1 (33.3) | NS |
HPV = human papillomavirus; IgG = immunoglobulinG; BTB = bladder tissue biopsy; BCC = buffy coat cells; NS = nonsignificant
Significant differences (P < .05)